Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Rheumatoid Arthritis

  Free Subscription


18.04.2017

2 Ann Rheum Dis
3 Arthritis Res Ther
8 Clin Rheumatol
1 Intern Med
1 PLoS One
3 Rheumatol Int


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Rheum Dis

  1. CRUZ GI, Shao X, Quach H, Ho KA, et al
    Increased risk of rheumatoid arthritis among mothers with children who carry DRB1 risk-associated alleles.
    Ann Rheum Dis. 2017 Apr 8. doi: 10.1136/annrheumdis-2016-210662.
    PubMed     Text format     Abstract available

  2. BURMESTER GR, Rigby WF, van Vollenhoven RF, Kay J, et al
    Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial.
    Ann Rheum Dis. 2017 Apr 7. pii: annrheumdis-2016-210561.
    PubMed     Text format     Abstract available


    Arthritis Res Ther

  3. KILTZ U, von Zabern C, Baraliakos X, Heldmann F, et al
    Diagnostic value of a 3-day course of prednisolone in patients with possible rheumatoid arthritis - the TryCort study.
    Arthritis Res Ther. 2017;19:73.
    PubMed     Text format     Abstract available

  4. TAKAHASHI S, Saegusa J, Sendo S, Okano T, et al
    Glutaminase 1 plays a key role in the cell growth of fibroblast-like synoviocytes in rheumatoid arthritis.
    Arthritis Res Ther. 2017;19:76.
    PubMed     Text format     Abstract available

  5. KUULIALA K, Kuuliala A, Koivuniemi R, Kautiainen H, et al
    Baseline JAK phosphorylation profile of peripheral blood leukocytes, studied by whole blood phosphospecific flow cytometry, is associated with 1-year treatment response in early rheumatoid arthritis.
    Arthritis Res Ther. 2017;19:75.
    PubMed     Text format     Abstract available


    Clin Rheumatol

  6. TOZ B, Erer B
    Rheumatologic manifestations of primary immunodeficiency diseases: comment on the study by Dimitriades et al.
    Clin Rheumatol. 2016;35:2625.
    PubMed     Text format    

  7. KABEERDOSS J, Sandhya P, Mandal SK, Gowri M, et al
    High salivary soluble L-selectin and interleukin-7 levels in Asian Indian patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2016;35:3063-3067.
    PubMed     Text format     Abstract available

  8. AKDEMIR G, Markusse IM, Goekoop-Ruiterman YP, Steup-Beekman GM, et al
    Rheumatologists' adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission.
    Clin Rheumatol. 2017;36:317-326.
    PubMed     Text format     Abstract available

  9. ITO T, Tamura N, Okuda S, Tada K, et al
    Elevated serum levels of soluble CD146 in patients with systemic sclerosis.
    Clin Rheumatol. 2017;36:119-124.
    PubMed     Text format     Abstract available

  10. CIPRIANI P, Berardicurti O, Masedu F, D'Onofrio F, et al
    Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study.
    Clin Rheumatol. 2017;36:251-260.
    PubMed     Text format     Abstract available

  11. XIAO F
    Neuromyotonia as an unusual neurological complication of primary Sjogren's syndrome: case report and literature review.
    Clin Rheumatol. 2017;36:481-484.
    PubMed     Text format     Abstract available

  12. LIU C, Zhang H, Yao G, Hu Y, et al
    Characteristics of primary Sjogren's syndrome patients with IgG4 positive plasma cells infiltration in the labial salivary glands.
    Clin Rheumatol. 2017;36:83-88.
    PubMed     Text format     Abstract available

  13. MUELLER RB, Reshiti N, Kaegi T, Finckh A, et al
    Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM).
    Clin Rheumatol. 2017;36:59-66.
    PubMed     Text format     Abstract available


    Intern Med

  14. INOUE R, Fujigaki Y, Kobayashi K, Tamura Y, et al
    Clinical Presentation of Tubulointerstitial Nephritis Caused by Amyloid Light-chain Amyloidosis in a Patient with Sjogren's Syndrome.
    Intern Med. 2017;56:419-423.
    PubMed     Text format     Abstract available


    PLoS One

  15. MORI S, Hidaka M, Kawakita T, Hidaka T, et al
    Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases.
    PLoS One. 2016;11:e0154744.
    PubMed     Text format     Abstract available


    Rheumatol Int

  16. TAN BE, Lim AL, Kan SL, Lim CH, et al
    Management of rheumatoid arthritis in clinical practice using treat-to-target strategy: Where do we stand in the multi-ethnic Malaysia population?
    Rheumatol Int. 2017 Apr 7. doi: 10.1007/s00296-017-3705.
    PubMed     Text format     Abstract available

  17. TADA M, Inui K, Sugioka Y, Mamoto K, et al
    Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
    Rheumatol Int. 2017 Apr 12. doi: 10.1007/s00296-017-3720.
    PubMed     Text format     Abstract available

  18. DE MIGUEL E, Pecondon-Espanol A, Castano-Sanchez M, Corrales A, et al
    A reduced 12-joint ultrasound examination predicts lack of X-ray progression better than clinical remission criteria in patients with rheumatoid arthritis.
    Rheumatol Int. 2017 Apr 7. doi: 10.1007/s00296-017-3714.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: